Who owns VIRPAX PHARMACEUTICALS INC?
- Ticker: VRPX
- CUSIP Number: 928251206
Tip: Access positions for across all investors
Analyze quarterly positions in Virpax Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Virpax Pharmaceuticals stock
Who bought or sold VIRPAX PHARMACEUTICALS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Citadel Advisors | 31k | $22k | 100% | Sep 2024 |
|
| Geode Capital Management | 28k | $19k | 100% | Sep 2024 |
|
| Tower Research Capital | 3.1k | $1.6k | 117% | Jun 2024 |
|
| Signature Resources Capital Management | 50.00 | $35.000000 | 0% | Sep 2024 |
|
| Bank of America Corporation | 37.00 | $25.999900 | 429% | Sep 2024 |
|
| Morgan Stanley | 15.00 | $7.999500 | 0% | Jun 2024 |
|
| Hantz Financial Services | 10.00 | $0 | 0% | Jun 2024 |
|
Who sold out of Virpax Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Warberg Asset Management | Jun 2024 | 20k | $10k |